A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ¥642.88, with a 24-hour trading volume of ¥4.77M. The asset's market cap is ¥1.99T, after moving -0.29% in the last day.
Tokenized AstraZeneca PLC is trading at ¥646.19, with a tokenized market cap of ¥4.84M and a 24-hour trading volume of ¥485.03K. The tokenized asset has moved 1.56% in the past 24 hours.